STACEY SMICK: Open Payments
NPI 1538160015 · BRIDGETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 80 payments from 18 companies in 2025. Trend: 2023 $1,386 · 2024 $1,752 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $251 |
| Novo Nordisk Inc | 17 | $248 |
| ABBVIE INC. | 14 | $182 |
| Lilly USA, LLC | 6 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| SHIELD THERAPEUTICS INC | 2 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| Amgen Inc. | 3 | $50 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, Kerendia, Ozempic, REXULTI, ACCRUFER, Wegovy.
Industry payments across NJ — which companies pay providers there.
